Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 21, 2024
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has acquired ZenBio Inc., a provider of advanced cell products and services. Together, BioIVT and ZenBio will offer an expanded portfolio of ...
read more
Wednesday, August 21, 2024
SGS announced the introduction of new specialized bioanalytical testing services in the North American pharmaceutical and biopharmaceutical markets.
read more
Audax Private Equity has entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. The deal is expected to close in the fourth quarter and is subject to regulatory approvals.
read more
Biotechnology companies and research organizations in UK and Canada are entering into a R&D project jointly funded by a £1.1 million grant from Innovate UK (part of UK Research and Innovation) and the National Research Council of Canada Industrial ...
read more
Sygnature Discovery announced a new addition to its leadership team, with the appointment of industry veteran Jade Dagher as General Manager for Canada.
read more
Wednesday, August 14, 2024
LSPedia, a provider of global product traceability, announced a strategic partnership with Pharma Logistics, a provider of pharmaceutical reverse distribution. This collaboration aims to transform the pharmaceutical supply chain by offering turnkey ...
read more
Wednesday, August 14, 2024
Champalimaud Foundation, a biomedical clinical research organization carrying out research and cutting-edge clinical development and discoveries that benefit people, and Lonza, a global manufacturing partner to the pharmaceutical, biotech and ...
read more
Wednesday, August 14, 2024
Evonik is collaborating with KNAUER Wissenschaftliche Geräte GmbH, a manufacturer of scientific instruments, to improve the upscaling of lipid nanoparticle (LNP) formulations. By combining Evonik’s formulation and scale-up expertise with KNAUER’s ...
read more
CiVentiChem, a contract development and manufacturing organization (CDMO), announced the completion of a new facility, significantly expanding its manufacturing capacity by 300%. This state-of-the-art facility will focus on producing Regulatory ...
read more
Ashland completed a second expansion of its pharmaceutical injectables manufacturing and R&D lab at the National Science Park in Mullingar, Ireland and will celebrate the moment with a ribbon-cutting ceremony on August 22, 2024.
read more
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for their Phase 1 clinical trial of AGX101, a first-in-class TM4SF1-directed Antibody-Drug Conjugate (ADC)...
read more
Thursday, August 08, 2024
WuXi Biologics and Medigene AG announced that they have entered into a three-year, multi-target strategic partnership to design and co-research T cell receptor (TCR)-guided T Cell Engagers (TCR-TCEs) for the treatment of difficult-to-treat tumors.
read more
Thursday, August 08, 2024
The Government of Canada , represented by Charles Sousa, Parliamentary Secretary to the Minister of Public Services and Procurement, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a ...
read more
Wednesday, August 07, 2024
Silo Pharma, Inc. announced that it has entered into an agreement with WuXi AppTec for a preclinical small animal study of SPU-16, a central nervous system (CNS) homing peptide targeting multiple sclerosis (MS).
read more
Wednesday, August 07, 2024
NovAliX has formed a strategic partnership with Bruker under which Bruker has taken a minority ownership stake in NovAliX. The strategic investment underscores the increasingly vital role being played by CROs in global drug discovery and research.
read more